Research Reveals Long COVID Hits the Young Harder Than the Old


It might sound counterintuitive, but new research shows that when long COVID strikes, younger patients appear more prone to severe symptoms than older folks. That's tough on society as a…[...]

COVID-19 infections may actually shrink cancerous tumors, shock study reveals


By The Conversation, Research led by Justin Stebbing, Anglia Ruskin University A fascinating new study, published in the Journal of Clinical Investigation, has revealed an unexpected potential benefit of severe COVID infection: it…[...]

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria


Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the…[...]

Ideological diversity of media consumption predicts COVID-19 vaccination


Marrissa D. Grant, David M. Markowitz, David K. Sherman, et. al., Scientific Reports volume 14, Article number: 28948 (2024)  Abstract This study examines the relationship between respondents’ vaccine hesitancy, reported media consumption patterns, ideological leanings, and…[...]

Evidence on Long COVID Diagnosis, Risk, Symptoms, and Functional Impact for Patients


News Release |  2024, National Academies of Sciences, Engineering, and Medicine WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents conclusions about Long COVID diagnosis, symptoms, and…[...]

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise


Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19…[...]

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection


Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute…[...]